	US 11,931,324 B2
	Pharmaceutical composition for prevention or treatment of osteoarthritis comprising obtusifolin, derivative thereof, or pharmaceutically acceptable salt thereof as active ingredient
Cheol-ho Pan, Seoul (KR); Kwang-hyun Cha, Seoul (KR); Song Yi Koo, Seoul (KR); Eun Ha Lee, Seoul (KR); and Hee Ju Lee, Seoul (KR)
Assigned to KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, Seoul (KR)
Filed by KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, Seoul (KR)
Filed on Mar. 8, 2022, as Appl. No. 17/689,665.
Claims priority of application No. 10-2021-0043512 (KR), filed on Apr. 2, 2021.
Prior Publication US 2022/0323377 A1, Oct. 13, 2022
Int. Cl. A61K 31/122 (2006.01); A23L 33/00 (2016.01); A23L 33/10 (2016.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01)

CPC A61K 31/122 (2013.01) [A23L 33/10 (2016.08); A23L 33/40 (2016.08); A61P 19/02 (2018.01); A61P 29/00 (2018.01); A23V 2002/00 (2013.01)]

1 Claim

1. A method for preventing or treating osteoarthritis, the method comprising:

administering obtusifolin, a derivative thereof, or a pharmaceutically acceptable salt thereof to a subject.